Model
Edge
Halozyme Therapeutics, Inc.
0001662521
Filing type
144
Filing date
Aug 9, 2026
Updated
Aug 10, 2026 ยท 2:34 PM
Copy reference
Filing
144
Notice of Proposed Sale of Securities